New Innovation, Need Execution

Research evidence excerpt

New Innovation, Need Execution

June 15, 2026 | 05:00 ET~

DXC Technology

DXC-NYSE Rating Price: Jun-12 Target Total Rtn IT Services

Market Perform $9.17 $10.00 9%

Keith Bachman, CFA Analyst

keith.bachman@bmo.com (347) 891-0258

Adam J. Holets Senior Associate

New Innovation, Need Execution adam.holets@bmo.com (646) 248-5505

Bradley Clark, CFA VP Associate

brad.clark@bmo.com (347) 853-4783

Bottom Line: Jonathan Stein Associate

We came away from DXC Investor Day modestly more positive on DXC’s strategy that jonathan.stein@bmo.com (718) 619-7165

included innovation across all three business segments. Moreover, we think DXC is Legal Entity: BMO Capital Markets Corp.

attempting to better re-position away from declining market segments towards more

2YR Price Volume Chart

growth-oriented segments. However, we remain on the sidelines as we await evidence 25

that DXC is successfully executing against strategic ambitions, particularly given unclear 20

monetization of new solutions that generate meaningful efficiency gains. No changes

to our target price, estimates, or rating. 15 30

Key Points 10

5 0

Dec Jun Dec Jun

New FY29 Revenue Target: DXC announced new FY29 financial targets including 0– LHS: Price ($) / RHS: Volume (mm) Source: FactSet

4% organic revenue growth. This includes a return to low to mid-single digit growth Company Data in $

in CES, mid-single digit growth in Insurance, and improvement to flattish GIS revenue.

Dividend $0.00 Shares O/S (mm) 162.1

A key assumption is that DXC generates a few points of incremental revenue growth

from newer led AI offerings such as Oasis while the “core” business improves towards Yield 0.0% Market Cap (mm) $1,486

flattish growth. The high-end of the range includes improvement in discretionary spend EV (mm) $3,315 AD Vol. (mm) 4.34